Publication

Xu B, Zhang J, Strom J, Lee S, Chen QM. 2014. Myocardial ischemic reperfusion induces de novo Nrf2 protein translation. Biochim Biophys Acta. 1842:1638–47. doi:10.1016/j.bbadis.2014.06.002.

Chow H-HS, Garland LL, Heckman-Stoddard BM, Hsu C-H, Butler VD, Cordova CA, Chew WM, Cornelison TL. 2014. A pilot clinical study of resveratrol in postmenopausal women with high body mass index: effects on systemic sex steroid hormones. J Transl Med. 12:223. doi:10.1186/s12967-014-0223-0.

Mahalingam D, Mita M, Sarantopoulos J, Wood L, Amaravadi RK, Davis LE, Mita AC, Curiel TJ, Espitia CM, Nawrocki ST, et al. 2014. Combined autophagy and HDAC inhibition: a phase I safety, tolerability, pharmacokinetic, and pharmacodynamic analysis of hydroxychloroquine in combination with the HDAC inhibitor vorinostat in patients with advanced solid tumors. Autophagy. 10:1403–14. doi:10.4161/auto.29231.

Sivendran S, Chang R, Pham L, Phelps RG, Harcharik ST, Hall LD, Bernardo SG, Moskalenko MM, Sivendran M, Fu Y, et al. 2014. Dissection of immune gene networks in primary melanoma tumors critical for antitumor surveillance of patients with stage II-III resectable disease. J Invest Dermatol. 134:2202–2211. doi:10.1038/jid.2014.85.

Hester AG, Murphy RC, Uhlson CJ, Ivester P, Lee TC, Sergeant S, Miller LR, Howard TD, Mathias RA, Chilton FH. 2014. Relationship between a common variant in the fatty acid desaturase (FADS) cluster and eicosanoid generation in humans. J Biol Chem. 289:22482–9. doi:10.1074/jbc.M114.579557.

Shanmugam I, Abbas M, Ayoub F, Mirabal S, Bsaili M, Caulder EK, Weinstock DM, Tomkinson AE, Hromas R, Shaheen M. 2014. Ubiquitin-specific peptidase 20 regulates Rad17 stability, checkpoint kinase 1 phosphorylation and DNA repair by homologous recombination. J Biol Chem. 289:22739–48. doi:10.1074/jbc.M114.550459.

Kumar S, Pan CC, Bloodworth JC, Nixon AB, Theuer C, Hoyt DG, Lee NY. 2014. Antibody-directed coupling of endoglin and MMP-14 is a key mechanism for endoglin shedding and deregulation of TGF-β signaling. Oncogene. 33:3970–9. doi:10.1038/onc.2013.386.

Hockenberry MJ, Taylor OA, Gundy PM, Ross AK, Pasvogel A, Montgomery D, Ribbeck P, McCarthy K, Moore I. 2014. F2-isoprostanes: a measure of oxidative stress in children receiving treatment for leukemia. Biol Res Nurs. 16:303–9. doi:10.1177/1099800413498507.

Krishnan N, Koveal D, Miller DH, Xue B, Akshinthala SD, Kragelj J, Jensen MR, Gauss C-M, Page R, Blackledge M, et al. 2014. Targeting the disordered C terminus of PTP1B with an allosteric inhibitor. Nat Chem Biol. 10:558–66. doi:10.1038/nchembio.1528.

Gomez C, Shah C, McCloskey S, Foster N, Vicini F. 2014. The role of radiation therapy after nipple-sparing mastectomy. Ann Surg Oncol. 21:2237–44. doi:10.1245/s10434-013-3446-z.

Mantyh PW. 2014. Bone cancer pain: from mechanism to therapy. Curr Opin Support Palliat Care. 8:83–90. doi:10.1097/SPC.0000000000000048.

Yao G. 2014. Modelling mammalian cellular quiescence. Interface Focus. 4:20130074. doi:10.1098/rsfs.2013.0074.

Chilton FH, Murphy RC, Wilson BA, Sergeant S, Ainsworth H, Seeds MC, Mathias RA. 2014. Diet-gene interactions and PUFA metabolism: a potential contributor to health disparities and human diseases. Nutrients. 6:1993–2022. doi:10.3390/nu6051993.

Smith AK, Conneely KN, Pace TWW, Mister D, Felger JC, Kilaru V, Akel MJ, Vertino PM, Miller AH, Torres MA. 2014. Epigenetic changes associated with inflammation in breast cancer patients treated with chemotherapy. Brain Behav Immun. 38:227–36. doi:10.1016/j.bbi.2014.02.010.

Ramos P, Karnezis AN, Craig DW, Sekulic A, Russell ML, Hendricks WPD, Corneveaux JJ, Barrett MT, Shumansky K, Yang Y, et al. 2014. Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4. Nat Genet. 46:427–9. doi:10.1038/ng.2928.

Abbas M, Shanmugam I, Bsaili M, Hromas R, Shaheen M. 2014. The role of the human psoralen 4 (hPso4) protein complex in replication stress and homologous recombination. J Biol Chem. 289:14009–19. doi:10.1074/jbc.M113.520056.

Braun KL, Tsark JU, Powers A, Croom K, Kim R, Gachupin FC, Morris P. 2014. Cancer patient perceptions about biobanking and preferred timing of consent. Biopreserv Biobank. 12:106–12. doi:10.1089/bio.2013.0083.

Miller CR, Oliver KE, Farley JH. 2014. MEK1/2 inhibitors in the treatment of gynecologic malignancies. Gynecol Oncol. 133:128–37. doi:10.1016/j.ygyno.2014.01.008.

Riahi R, Yang YL, Kim H, Jiang L, Wong PK, Zohar Y. 2014. A microfluidic model for organ-specific extravasation of circulating tumor cells. Biomicrofluidics. 8:024103. doi:10.1063/1.4868301.

Hatcher-Keller J, Rayens MK, Dignan M, Schoenberg N, Allison P. 2014. Beliefs regarding mammography screening among women visiting the emergency department for nonurgent care. J Emerg Nurs. 40:e27–35. doi:10.1016/j.jen.2013.01.015.

Weinstein RS, López AM, Joseph BA, Erps KA, Holcomb M, Barker GP, Krupinski EA. 2014. Telemedicine, telehealth, and mobile health applications that work: opportunities and barriers. Am J Med. 127:183–7. doi:10.1016/j.amjmed.2013.09.032.

Cusanovich DA, Pavlovic B, Pritchard JK, Gilad Y. 2014. The functional consequences of variation in transcription factor binding. PLoS Genet. 10:e1004226. doi:10.1371/journal.pgen.1004226.

Crane TE, Khulpateea BR, Alberts DS, Basen-Engquist K, Thomson CA. 2014. Dietary intake and ovarian cancer risk: a systematic review. Cancer Epidemiol Biomarkers Prev. 23:255–73. doi:10.1158/1055-9965.EPI-13-0515.

Tredwell GD, Miller JA, Chow H-HS, Thompson PA, Keun HC. 2014. Metabolomic characterization of nipple aspirate fluid by (1)H NMR spectroscopy and GC-MS. J Proteome Res. 13:883–9. doi:10.1021/pr400924k.

Garcia FAR, Cornelison T, Nuño T, Greenspan DL, Byron JW, Hsu C-H, Alberts DS, Chow H-HS. 2014. Results of a phase II randomized, double-blind, placebo-controlled trial of Polyphenon E in women with persistent high-risk HPV infection and low-grade cervical intraepithelial neoplasia. Gynecol Oncol. 132:377–82. doi:10.1016/j.ygyno.2013.12.034.